In this study, we used the pilocarpine model of epilepsy to evaluate the involvement of calpain dysregulation on epileptogenesis. Detection of spectrin breakdown products (SBDPs, a hallmark of calpain activation) after induction of pilocarpine-induced status epilepticus (SE) and before appearance of spontaneous seizure suggested the existence of sustained calpain activation during epileptogenesis. Acute treatment with a cell permeable inhibitor of calpain, MDL-28170, resulted in a partial but significant reduction on seizure burden. The reduction on seizure burden was associated with a limited reduction on the generation of SBDPs but was correlated with a reduction in astrocytosis, microglia activation and cell sprouting. Together, these observations provide evidence for the role of calpain in epileptogenesis. In addition, provide proof-of-principle for the use of calpain inhibitors as a novel strategy to prevent epileptic seizures and its associated pathologies.
Introduction
Epilepsy is a chronic disease characterized by the occurrence of spontaneous recurrent seizures (SRS) arising from abnormal neuronal hyperexcitability and synchronization (Kumar and Buckmaster, 2006; El-Hassar et al., 2007; Fritschy, 2008; Williams et al., 2009; O'Dell et al., 2012) . In humans, almost half of individuals experiencing de novo status epilepticus (SE) develop epilepsy after a seizure-free interval (Annegers et al., 1987; French et al., 1993; Tsai et al., 2009) . A short seizure-free interval (latent period) also precedes the appearance of spontaneous seizures in chemoconvulsant (pilocarpine or kainate) models of temporal lobe epilepsy (TLE) (Sharma et al., 2007; Loscher and Brandt, 2010; O'Dell et al., 2012) . In addition to recurrent seizures, rodents enduring chemoconvulsant-induced epilepsy demonstrate brain lesions (neuronal loss, astrogliosis, mossy fiber sprouting and hippocampal sclerosis) highly isomorphic to the human condition (Sharma et al., 2007; Curia et al., 2008; Pitkanen and Lukasiuk, 2009) .
The calcium-dependent proteases with papain-like activity (calpains) belong to a family of non-lysosomal cysteine proteases activated by calcium (Campbell and Davies, 2012; Ono and Sorimachi, 2012) . Two major calpain isoforms are ubiquitously expressed in the brain: calpain-1 and calpain-2 (Liu et al., 2008; Saatman et al., 2010; Baudry and Bi, 2016) . Following a brain injury, a sustained increase in intracellular calcium results in calpain activation (Liu et al., 2008; Saatman et al., 2010) . Calpain activation can be readily detected following brain injury induced by chemoconvulsants (pilocarpine or kainate) typically used to triggered SE (Bi et al., 1996; Araujo et al., 2008; Wang et al., 2008) . As such, there is evidence that sustained calpain activation contributes to both chronic and acute neurodegeneration in a wide range of pathologic conditions including SE (Vanderklish and Bahr, 2000; Bevers and Neumar, 2008; Vosler et al., 2008; Saatman et al., 2010) . Pharmacological inhibition of calpain after chemoconvulsant-induced SE provides neuroprotection (Araujo et al., 2008; Wang et al., 2008) , suggesting that calpains have an active contribution to the acute neurodegenerative process. Moreover, analysis of tissue obtained from patients with epilepsy showed increased calpain expression (Feng et al., 2011; Das et al., 2012) . Despite this knowledge, the contribution of calpain overactivation to the epileptogenic process remains poorly studied.
Due to the existence of a close correlation between calpain activation and a broad range of proteins that can be cleaved by this protease, calpain inhibition is an attractive therapeutic target (Vosler et al., 2008; Saatman et al., 2010) . As an additional feature, calpain inhibition is expected to have few side effects since the basal levels of calpain activation prevailing in the normal brain is relatively low (Saatman et al., 2010) . Here, we report the effects of a calpain inhibitor on several aspects linked to epileptogenesis including seizure burden and cellular pathologies associated to seizure occurrence. Our findings suggest that Abbreviations: TLE, temporal lobe epilepsy; SE, status epilepticus; CA1, Cornus Ammonis 1; DG, dentate gyrus; FJB, Fluoro-Jade B; GFAP, glial fibrillary acidic protein; Iba-1, ionized calcium-binding adaptor molecule 1; EEG, electroencephalogram; SBDPs, α-spectrin breakdown products; ZNT3, Zinc Transporter 3; IL-1, interleukin 1; PBS, phosphate buffered saline.
